Lipid metabolism in myeloid cell function and chronic inflammatory diseases

Immune cells adapt their metabolism in response to their differentiation and activation status to meet the energy demands for an appropriate immune response. Recent studies have elucidated that during immune cell metabolic reprogramming, lipid metabolism, including lipid uptake, de novo lipid synthe...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayaka Ito, Takayoshi Suganami
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1495853/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591898669219840
author Ayaka Ito
Ayaka Ito
Ayaka Ito
Takayoshi Suganami
Takayoshi Suganami
Takayoshi Suganami
Takayoshi Suganami
author_facet Ayaka Ito
Ayaka Ito
Ayaka Ito
Takayoshi Suganami
Takayoshi Suganami
Takayoshi Suganami
Takayoshi Suganami
author_sort Ayaka Ito
collection DOAJ
description Immune cells adapt their metabolism in response to their differentiation and activation status to meet the energy demands for an appropriate immune response. Recent studies have elucidated that during immune cell metabolic reprogramming, lipid metabolism, including lipid uptake, de novo lipid synthesis and fatty acid oxidation, undergoes significant alteration, resulting in dynamic changes in the quantity and quality of intracellular lipids. Given that lipids serve as an energy source and structural components of cellular membranes, they have important implications for physiological function. Myeloid cells, which are essential in bridging innate and adaptive immunity, are sensitive to these changes. Dysregulation of lipid metabolism in myeloid cells can result in immune dysfunction, chronic inflammation and impaired resolution of inflammation. Understanding the mechanism by which lipids regulate immune cell function might provide novel therapeutic insights into chronic inflammatory diseases, including metabolic diseases, autoimmune diseases and cancer. (143 words)
format Article
id doaj-art-307a878304ac4feb9641a779892ec77b
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-307a878304ac4feb9641a779892ec77b2025-01-22T05:19:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.14958531495853Lipid metabolism in myeloid cell function and chronic inflammatory diseasesAyaka Ito0Ayaka Ito1Ayaka Ito2Takayoshi Suganami3Takayoshi Suganami4Takayoshi Suganami5Takayoshi Suganami6Department of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, Nagoya, JapanDepartment of Immunometabolism, Nagoya University Graduate School of Medicine, Nagoya, JapanInstitute for Advanced Research, Nagoya University, Nagoya, JapanDepartment of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, Nagoya, JapanDepartment of Immunometabolism, Nagoya University Graduate School of Medicine, Nagoya, JapanInstitute of Nano-Life-Systems, Institutes of Innovation for Future Society, Nagoya University, Nagoya, JapanCenter for One Medicine Innovative Translational Research (COMIT), Nagoya University, Nagoya, JapanImmune cells adapt their metabolism in response to their differentiation and activation status to meet the energy demands for an appropriate immune response. Recent studies have elucidated that during immune cell metabolic reprogramming, lipid metabolism, including lipid uptake, de novo lipid synthesis and fatty acid oxidation, undergoes significant alteration, resulting in dynamic changes in the quantity and quality of intracellular lipids. Given that lipids serve as an energy source and structural components of cellular membranes, they have important implications for physiological function. Myeloid cells, which are essential in bridging innate and adaptive immunity, are sensitive to these changes. Dysregulation of lipid metabolism in myeloid cells can result in immune dysfunction, chronic inflammation and impaired resolution of inflammation. Understanding the mechanism by which lipids regulate immune cell function might provide novel therapeutic insights into chronic inflammatory diseases, including metabolic diseases, autoimmune diseases and cancer. (143 words)https://www.frontiersin.org/articles/10.3389/fimmu.2024.1495853/fulllipid metabolismimmunometabolismautoimmunitycancermetabolic disease
spellingShingle Ayaka Ito
Ayaka Ito
Ayaka Ito
Takayoshi Suganami
Takayoshi Suganami
Takayoshi Suganami
Takayoshi Suganami
Lipid metabolism in myeloid cell function and chronic inflammatory diseases
Frontiers in Immunology
lipid metabolism
immunometabolism
autoimmunity
cancer
metabolic disease
title Lipid metabolism in myeloid cell function and chronic inflammatory diseases
title_full Lipid metabolism in myeloid cell function and chronic inflammatory diseases
title_fullStr Lipid metabolism in myeloid cell function and chronic inflammatory diseases
title_full_unstemmed Lipid metabolism in myeloid cell function and chronic inflammatory diseases
title_short Lipid metabolism in myeloid cell function and chronic inflammatory diseases
title_sort lipid metabolism in myeloid cell function and chronic inflammatory diseases
topic lipid metabolism
immunometabolism
autoimmunity
cancer
metabolic disease
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1495853/full
work_keys_str_mv AT ayakaito lipidmetabolisminmyeloidcellfunctionandchronicinflammatorydiseases
AT ayakaito lipidmetabolisminmyeloidcellfunctionandchronicinflammatorydiseases
AT ayakaito lipidmetabolisminmyeloidcellfunctionandchronicinflammatorydiseases
AT takayoshisuganami lipidmetabolisminmyeloidcellfunctionandchronicinflammatorydiseases
AT takayoshisuganami lipidmetabolisminmyeloidcellfunctionandchronicinflammatorydiseases
AT takayoshisuganami lipidmetabolisminmyeloidcellfunctionandchronicinflammatorydiseases
AT takayoshisuganami lipidmetabolisminmyeloidcellfunctionandchronicinflammatorydiseases